Malignant perinatal variant of long-QT syndrome caused by a profoundly dysfunctional cardiac sodium channel.

Dao W. Wang, Lia Crotti, Wataru Shimizu, Matteo Pedrazzini, Francesco Cantu, Paolo De Filippo, Kanako Kishiki, Aya Miyazaki, Tomoaki Ikeda, Peter J. Schwartz, Alfred L. George

Research output: Contribution to journalArticle

Abstract

BACKGROUND: Inherited cardiac arrhythmia susceptibility contributes to sudden death during infancy and may contribute to perinatal and neonatal mortality, but the molecular basis of this risk and the relationship to genetic disorders presenting later in life is unclear. We studied the functional and pharmacological properties of a novel de novo cardiac sodium channel gene (SCN5A) mutation associated with an extremely severe perinatal presentation of long-QT syndrome in unrelated probands of different ethnicity. METHODS AND RESULTS: Two subjects exhibiting severe fetal and perinatal ventricular arrhythmias were screened for SCN5A mutations, and the functional properties of a novel missense mutation (G1631D) were determined by whole-cell patch clamp recording. In vitro electrophysiological studies revealed a profound defect in sodium channel function characterized by approximately 10-fold slowing of inactivation, increased persistent current, slowing of recovery from inactivation, and depolarized voltage dependence of activation and inactivation. Single-channel recordings demonstrated increased frequency of late openings, prolonged mean open time, and increased latency to first opening for the mutant. Subjects carrying this mutation responded clinically to the combination of mexiletine with propranolol and survived. Pharmacologically, the mutant exhibited 2-fold greater tonic and use-dependent mexiletine block than wild-type channels. The mutant also exhibited enhanced tonic (2.4-fold) and use-dependent block ( approximately 5-fold) by propranolol, and we observed additive effects of the 2 drugs on the mutant. CONCLUSIONS: Our study demonstrates the molecular basis for a malignant perinatal presentation of long-QT syndrome, illustrates novel functional and pharmacological properties of SCN5A-G1631D, which caused the disorder, and reveals therapeutic benefits of propranolol block of mutant sodium channels in this setting.

Original languageEnglish
Pages (from-to)370-378
Number of pages9
JournalCirculation: Arrhythmia and Electrophysiology
Volume1
Issue number5
DOIs
Publication statusPublished - Dec 2008

Fingerprint

Long QT Syndrome
Sodium Channels
Propranolol
Mexiletine
Mutation
Cardiac Arrhythmias
Pharmacology
Inborn Genetic Diseases
Perinatal Mortality
Infant Mortality
Missense Mutation
Sudden Death
Pharmaceutical Preparations
Genes
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Malignant perinatal variant of long-QT syndrome caused by a profoundly dysfunctional cardiac sodium channel. / Wang, Dao W.; Crotti, Lia; Shimizu, Wataru; Pedrazzini, Matteo; Cantu, Francesco; De Filippo, Paolo; Kishiki, Kanako; Miyazaki, Aya; Ikeda, Tomoaki; Schwartz, Peter J.; George, Alfred L.

In: Circulation: Arrhythmia and Electrophysiology, Vol. 1, No. 5, 12.2008, p. 370-378.

Research output: Contribution to journalArticle

Wang, Dao W. ; Crotti, Lia ; Shimizu, Wataru ; Pedrazzini, Matteo ; Cantu, Francesco ; De Filippo, Paolo ; Kishiki, Kanako ; Miyazaki, Aya ; Ikeda, Tomoaki ; Schwartz, Peter J. ; George, Alfred L. / Malignant perinatal variant of long-QT syndrome caused by a profoundly dysfunctional cardiac sodium channel. In: Circulation: Arrhythmia and Electrophysiology. 2008 ; Vol. 1, No. 5. pp. 370-378.
@article{c407559a6f474937bcfadef78450ed69,
title = "Malignant perinatal variant of long-QT syndrome caused by a profoundly dysfunctional cardiac sodium channel.",
abstract = "BACKGROUND: Inherited cardiac arrhythmia susceptibility contributes to sudden death during infancy and may contribute to perinatal and neonatal mortality, but the molecular basis of this risk and the relationship to genetic disorders presenting later in life is unclear. We studied the functional and pharmacological properties of a novel de novo cardiac sodium channel gene (SCN5A) mutation associated with an extremely severe perinatal presentation of long-QT syndrome in unrelated probands of different ethnicity. METHODS AND RESULTS: Two subjects exhibiting severe fetal and perinatal ventricular arrhythmias were screened for SCN5A mutations, and the functional properties of a novel missense mutation (G1631D) were determined by whole-cell patch clamp recording. In vitro electrophysiological studies revealed a profound defect in sodium channel function characterized by approximately 10-fold slowing of inactivation, increased persistent current, slowing of recovery from inactivation, and depolarized voltage dependence of activation and inactivation. Single-channel recordings demonstrated increased frequency of late openings, prolonged mean open time, and increased latency to first opening for the mutant. Subjects carrying this mutation responded clinically to the combination of mexiletine with propranolol and survived. Pharmacologically, the mutant exhibited 2-fold greater tonic and use-dependent mexiletine block than wild-type channels. The mutant also exhibited enhanced tonic (2.4-fold) and use-dependent block ( approximately 5-fold) by propranolol, and we observed additive effects of the 2 drugs on the mutant. CONCLUSIONS: Our study demonstrates the molecular basis for a malignant perinatal presentation of long-QT syndrome, illustrates novel functional and pharmacological properties of SCN5A-G1631D, which caused the disorder, and reveals therapeutic benefits of propranolol block of mutant sodium channels in this setting.",
author = "Wang, {Dao W.} and Lia Crotti and Wataru Shimizu and Matteo Pedrazzini and Francesco Cantu and {De Filippo}, Paolo and Kanako Kishiki and Aya Miyazaki and Tomoaki Ikeda and Schwartz, {Peter J.} and George, {Alfred L.}",
year = "2008",
month = "12",
doi = "10.1161/CIRCEP.108.788349",
language = "English",
volume = "1",
pages = "370--378",
journal = "Circulation: Arrhythmia and Electrophysiology",
issn = "1941-3149",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Malignant perinatal variant of long-QT syndrome caused by a profoundly dysfunctional cardiac sodium channel.

AU - Wang, Dao W.

AU - Crotti, Lia

AU - Shimizu, Wataru

AU - Pedrazzini, Matteo

AU - Cantu, Francesco

AU - De Filippo, Paolo

AU - Kishiki, Kanako

AU - Miyazaki, Aya

AU - Ikeda, Tomoaki

AU - Schwartz, Peter J.

AU - George, Alfred L.

PY - 2008/12

Y1 - 2008/12

N2 - BACKGROUND: Inherited cardiac arrhythmia susceptibility contributes to sudden death during infancy and may contribute to perinatal and neonatal mortality, but the molecular basis of this risk and the relationship to genetic disorders presenting later in life is unclear. We studied the functional and pharmacological properties of a novel de novo cardiac sodium channel gene (SCN5A) mutation associated with an extremely severe perinatal presentation of long-QT syndrome in unrelated probands of different ethnicity. METHODS AND RESULTS: Two subjects exhibiting severe fetal and perinatal ventricular arrhythmias were screened for SCN5A mutations, and the functional properties of a novel missense mutation (G1631D) were determined by whole-cell patch clamp recording. In vitro electrophysiological studies revealed a profound defect in sodium channel function characterized by approximately 10-fold slowing of inactivation, increased persistent current, slowing of recovery from inactivation, and depolarized voltage dependence of activation and inactivation. Single-channel recordings demonstrated increased frequency of late openings, prolonged mean open time, and increased latency to first opening for the mutant. Subjects carrying this mutation responded clinically to the combination of mexiletine with propranolol and survived. Pharmacologically, the mutant exhibited 2-fold greater tonic and use-dependent mexiletine block than wild-type channels. The mutant also exhibited enhanced tonic (2.4-fold) and use-dependent block ( approximately 5-fold) by propranolol, and we observed additive effects of the 2 drugs on the mutant. CONCLUSIONS: Our study demonstrates the molecular basis for a malignant perinatal presentation of long-QT syndrome, illustrates novel functional and pharmacological properties of SCN5A-G1631D, which caused the disorder, and reveals therapeutic benefits of propranolol block of mutant sodium channels in this setting.

AB - BACKGROUND: Inherited cardiac arrhythmia susceptibility contributes to sudden death during infancy and may contribute to perinatal and neonatal mortality, but the molecular basis of this risk and the relationship to genetic disorders presenting later in life is unclear. We studied the functional and pharmacological properties of a novel de novo cardiac sodium channel gene (SCN5A) mutation associated with an extremely severe perinatal presentation of long-QT syndrome in unrelated probands of different ethnicity. METHODS AND RESULTS: Two subjects exhibiting severe fetal and perinatal ventricular arrhythmias were screened for SCN5A mutations, and the functional properties of a novel missense mutation (G1631D) were determined by whole-cell patch clamp recording. In vitro electrophysiological studies revealed a profound defect in sodium channel function characterized by approximately 10-fold slowing of inactivation, increased persistent current, slowing of recovery from inactivation, and depolarized voltage dependence of activation and inactivation. Single-channel recordings demonstrated increased frequency of late openings, prolonged mean open time, and increased latency to first opening for the mutant. Subjects carrying this mutation responded clinically to the combination of mexiletine with propranolol and survived. Pharmacologically, the mutant exhibited 2-fold greater tonic and use-dependent mexiletine block than wild-type channels. The mutant also exhibited enhanced tonic (2.4-fold) and use-dependent block ( approximately 5-fold) by propranolol, and we observed additive effects of the 2 drugs on the mutant. CONCLUSIONS: Our study demonstrates the molecular basis for a malignant perinatal presentation of long-QT syndrome, illustrates novel functional and pharmacological properties of SCN5A-G1631D, which caused the disorder, and reveals therapeutic benefits of propranolol block of mutant sodium channels in this setting.

UR - http://www.scopus.com/inward/record.url?scp=70350506309&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70350506309&partnerID=8YFLogxK

U2 - 10.1161/CIRCEP.108.788349

DO - 10.1161/CIRCEP.108.788349

M3 - Article

C2 - 19808432

AN - SCOPUS:70350506309

VL - 1

SP - 370

EP - 378

JO - Circulation: Arrhythmia and Electrophysiology

JF - Circulation: Arrhythmia and Electrophysiology

SN - 1941-3149

IS - 5

ER -